---
title: 'Oxytocin in old age psychiatry: A systematic review of the safety of using
  intranasal oxytocin in older adults'
date: '2024-10-30'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39474844/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20241030210344&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSION: In a population of older adults, intranasal oxytocin is
  devoid of serious adverse events. Although this review offers valuable insights,
  it may not fully reflect the potential adverse events associated with the long-term
  administration of intranasal oxytocin such as would be expected in its clinical
  application if approved for the treatment of ...'
disable_comments: true
---
CONCLUSION: In a population of older adults, intranasal oxytocin is devoid of serious adverse events. Although this review offers valuable insights, it may not fully reflect the potential adverse events associated with the long-term administration of intranasal oxytocin such as would be expected in its clinical application if approved for the treatment of ...